The effects of inhaled aztreonam on the cystic fibrosis lung microbiome

BACKGROUND: Aztreonam lysine for inhalation (AZLI) is an inhaled antibiotic used to treat chronic Pseudomonas aeruginosa infection in CF. AZLI improves lung function and quality of life, and reduces exacerbations-improvements attributed to its antipseudomonal activity. Given the extremely high aztre...

Descripción completa

Detalles Bibliográficos
Autores principales: Heirali, Alya A., Workentine, Matthew L., Acosta, Nicole, Poonja, Ali, Storey, Douglas G., Somayaji, Ranjani, Rabin, Harvey R., Whelan, Fiona J., Surette, Michael G., Parkins, Michael D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5420135/
https://www.ncbi.nlm.nih.gov/pubmed/28476135
http://dx.doi.org/10.1186/s40168-017-0265-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5420135/
https://www.ncbi.nlm.nih.gov/pubmed/28476135
http://dx.doi.org/10.1186/s40168-017-0265-7

Ejemplares similares